<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Coherus Oncology Inc (CHRS)</title>
    <description>Latest news, press releases, and SEC filings for Coherus Oncology Inc (CHRS)</description>
    <link>https://caymanjournal.com/stock/CHRS</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 22:46:56 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/CHRS/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>DEF 14A — Coherus Oncology, Inc.</title>
      <description># 📜 What This Document Is 🗓️
This document is a Definitive Proxy Statement (DEF 14A). Think of it as an annual report card for shareholders, telling you everything the company needs you to know before you vote at the upcoming Annual Meeting. It isn&apos;t a financial report itself, but rather a guide t</description>
      <link>https://caymanjournal.com/stock/CHRS/sec-filing/0001104659-26-045251</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/CHRS/sec-filing/0001104659-26-045251</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>